MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life

M Maenhout; Max Peters; Marinus A. Moerland; Richard P. Meijer; Maurice A.A.J. van den Bosch; Steven J. Frank; Paul L. Nguyen; Marco van Vulpen; Jochem R.N. van der Voort van Zyp

doi:https://doi.org/10.1016/j.radonc.2018.07.019

doi.org/10.1016/j.radonc.2018.07.019

MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life

,

,

..., Jochem R.N. van der Voort van Zyp

15

Radiotherapy and Oncology5.70

Volume: 129, Issue: 3, Pages: 554 - 560

Published: Dec 1, 2018

Abstract

Purpose To describe toxicity, biochemical outcome and quality of life after MRI guided focal high dose rate brachytherapy (HDR-BT) in a single fraction of 19 Gy for localized prostate cancer. Materials and methods Between May 2013 and April 2016, 30 patients were treated by MRI-guided focal HDR-BT. Patients with visible tumour on MRI were included. All patients were ≥65 years, T-stage

Paper Fields

Paper Details

Title

MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life

DOI

doi.org/10.1016/j.radonc.2018.07.019

Published Date

Dec 1, 2018

Journal

Radiotherapy and Oncology

Volume

129

Issue

3

Pages

554 - 560

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History